{"id":"https://openalex.org/W4362546895","doi":"https://doi.org/10.1158/2643-3230.c.6550449.v1","title":"Data from Scalable Manufacturing of CAR T Cells for Cancer Immunotherapy","display_name":"Data from Scalable Manufacturing of CAR T Cells for Cancer Immunotherapy","publication_year":2023,"publication_date":"2023-04-04","ids":{"openalex":"https://openalex.org/W4362546895","doi":"https://doi.org/10.1158/2643-3230.c.6550449.v1"},"language":"en","primary_location":{"id":"doi:10.1158/2643-3230.c.6550449.v1","doi":"https://doi.org/10.1158/2643-3230.c.6550449.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/2643-3230.c.6550449.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"http://dx.doi.org/10.1158/2643-3230.c.6550449.v1","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5078696390","display_name":"Mohamed Abou\u2010El\u2010Enein","orcid":"https://orcid.org/0000-0003-2903-9040","observed_orcids":["https://orcid.org/0000-0003-2903-9040"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mohamed Abou-el-Enein","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-2903-9040","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004489769","display_name":"Magdi Elsallab","orcid":"https://orcid.org/0000-0001-9574-3496","observed_orcids":["https://orcid.org/0000-0001-9574-3496"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Magdi Elsallab","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9574-3496","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032315182","display_name":"Steven A. Feldman","orcid":"https://orcid.org/0000-0003-2098-3860","observed_orcids":["https://orcid.org/0000-0003-2098-3860"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Steven A. Feldman","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-2098-3860","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073009158","display_name":"Andrew D. Fesnak","orcid":"https://orcid.org/0000-0002-2705-803X","observed_orcids":["https://orcid.org/0000-0002-2705-803X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andrew D. Fesnak","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021029688","display_name":"Helen Elisabeth Heslop","orcid":"https://orcid.org/0000-0001-7049-7698","observed_orcids":["https://orcid.org/0000-0001-7049-7698"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Helen E. Heslop","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-7049-7698","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000410098","display_name":"Peter W Marks","orcid":"https://orcid.org/0000-0001-5619-4404","observed_orcids":["https://orcid.org/0000-0001-5619-4404"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Peter Marks","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037938194","display_name":"Brian G. Till","orcid":"https://orcid.org/0000-0002-4718-8288","observed_orcids":["https://orcid.org/0000-0002-4718-8288"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Brian G. Till","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Gerhard Bauer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gerhard Bauer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5065544223","display_name":"Barbara Savoldo","orcid":"https://orcid.org/0000-0002-7571-3887","observed_orcids":["https://orcid.org/0000-0002-7571-3887"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Barbara Savoldo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10613","display_name":"Virus-based gene therapy research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/car-t-cell-manufacturing","display_name":"CAR T cell manufacturing","score":0.8550000190734863},{"id":"https://openalex.org/keywords/chimeric-antigen-receptor-t-cells","display_name":"chimeric antigen receptor T cells","score":0.9309999942779541},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.8190000057220459},{"id":"https://openalex.org/keywords/scalable-fabrication","display_name":"scalable fabrication","score":0.41499999165534973},{"id":"https://openalex.org/keywords/good-manufacturing-practices","display_name":"good manufacturing practices","score":0.9210000038146973},{"id":"https://openalex.org/keywords/hematologic-malignancies","display_name":"hematologic malignancies","score":0.8230000138282776},{"id":"https://openalex.org/keywords/production-time-reduction","display_name":"production time reduction","score":0.8500000238418579},{"id":"https://openalex.org/keywords/regulatory-challenges","display_name":"regulatory challenges","score":0.8859999775886536},{"id":"https://openalex.org/keywords/production-optimization","display_name":"production optimization","score":0.8539999723434448}],"concepts":[{"id":"https://openalex.org/C3875195","wikidata":"https://www.wikidata.org/wiki/Q5099363","display_name":"Chimeric antigen receptor","level":4,"score":0.663132905960083},{"id":"https://openalex.org/C2778348673","wikidata":"https://www.wikidata.org/wiki/Q739302","display_name":"Production (economics)","level":2,"score":0.5010218620300293},{"id":"https://openalex.org/C48044578","wikidata":"https://www.wikidata.org/wiki/Q727490","display_name":"Scalability","level":2,"score":0.43979811668395996},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.41639983654022217},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.4076499938964844},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.40329211950302124},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.379483699798584},{"id":"https://openalex.org/C117671659","wikidata":"https://www.wikidata.org/wiki/Q11049265","display_name":"Manufacturing engineering","level":1,"score":0.3321642279624939},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.33043575286865234},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.26480263471603394},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.18281260132789612},{"id":"https://openalex.org/C77088390","wikidata":"https://www.wikidata.org/wiki/Q8513","display_name":"Database","level":1,"score":0.09916150569915771},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.0887821614742279},{"id":"https://openalex.org/C139719470","wikidata":"https://www.wikidata.org/wiki/Q39680","display_name":"Macroeconomics","level":1,"score":0.0},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/2643-3230.c.6550449.v1","doi":"https://doi.org/10.1158/2643-3230.c.6550449.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/2643-3230.c.6550449.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/2643-3230.c.6550449.v1","doi":"https://doi.org/10.1158/2643-3230.c.6550449.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/2643-3230.c.6550449.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":0.8048999905586243,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7124319288","https://openalex.org/W3190521604","https://openalex.org/W4394843957","https://openalex.org/W2796911502","https://openalex.org/W4405098089","https://openalex.org/W7138351499","https://openalex.org/W7117970125","https://openalex.org/W3130829651","https://openalex.org/W2443085751","https://openalex.org/W3000883312"],"abstract_inverted_index":{"Abstract":[0],"As":[1,105],"of":[2,24,135,148],"April":[3],"2021,":[4],"there":[5,33],"are":[6,121,126],"five":[7],"commercially":[8],"available":[9],"chimeric":[10],"antigen":[11],"receptor":[12],"(CAR)":[13],"T":[14,26,66,90,110,151],"cell":[15,27,67,91,111],"therapies":[16],"for":[17,55,101,108],"hematologic":[18],"malignancies.":[19],"With":[20],"the":[21,52,106,146],"current":[22,64],"transition":[23],"CAR":[25,65,89,109,150],"manufacturing":[28,69,92],"from":[29],"academia":[30],"to":[31,46,50,87,98,142],"industry,":[32],"is":[34],"a":[35,132],"shift":[36],"toward":[37],"Good":[38],"Manufacturing":[39],"Practice":[40],"(GMP)\u2013compliant":[41],"closed":[42,116],"and":[43,49,71,79,94,117,124,144],"automated":[44,118],"systems":[45],"ensure":[47],"reproducibility":[48],"meet":[51],"increased":[53],"demand":[54,107],"patients":[56],"with":[57],"cancer.":[58],"In":[59],"this":[60],"review,":[61],"we":[62],"describe":[63],"clinical":[68,102],"models":[70],"discuss":[72],"emerging":[73],"technologic":[74],"advances":[75],"that":[76],"embrace":[77],"scaling":[78,99],"production":[80,100,119,147],"optimization.":[81],"We":[82],"summarize":[83],"measures":[84],"being":[85,122],"used":[86],"shorten":[88],"times":[93],"highlight":[95],"regulatory":[96],"challenges":[97],"use.":[103],"Significance:":[104],"cancer":[112],"therapy":[113],"increases,":[114],"several":[115],"platforms":[120],"deployed,":[123],"others":[125],"in":[127],"development.":[128],"This":[129],"review":[130],"provides":[131],"critical":[133],"appraisal":[134],"these":[136],"technologies,":[137],"which":[138],"can":[139],"be":[140],"leveraged":[141],"scale":[143],"optimize":[145],"next-generation":[149],"cells.":[152],"See":[153],"related":[154],"video:https://aacrjournals.org/content/webinar-car-t-cell-manufacturing":[155]},"counts_by_year":[],"updated_date":"2026-09-27T08:07:27.782135","created_date":"2023-04-06T00:00:00"}